Advancing kidney disease research through integrated genetic and real-world evidence

https://www.statnews.com/sponsor/2026/05/01/advancing-kidney-disease-research-through-integrated-genetic-and-real-world-evidence/ Chronic kidney disease affects more than 850 million people worldwide and remains a major global health burden.¹ Despite that scale, kidney disease research and therapeutic development have historically progressed more slowly than in many other areas of medicine. One reason is that the data needed to understand these diseases is often fragmented, making it difficult to draw clear conclusions about disease drivers, patient variability, and treatment opportunities.